论文信息 - Impacts of Cytogenetic Abnormalities and Prior Alemtuzumab on Outcomes of Patients (pts) with High-Risk Chronic Lymphocytic Leukemia (CLL) Given Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT) - 字舞流文

Impacts of Cytogenetic Abnormalities and Prior Alemtuzumab on Outcomes of Patients (pts) with High-Risk Chronic Lymphocytic Leukemia (CLL) Given Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT)

M. Sorror | R. Storb | B. Sandmaier | D. Maloney | B. Storer | P. Mcsweeney | M. Pulsipher | R. Maziarz | M. Maris | C. Bredeson | A. Langston | B. Bruno | L. Vindeløv | T. Chauncey | G. Laport | F. Sahebi | E. Agura | L. Braunert